Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Overall response · patients with EOC

Topotecon may leads to lower overall response compared with topotecon+thalidomide (low certainty).

1 finding from 1 review

Topotecan for ovarian cancer 2008 · Cochrane Headline outcomes only
RR 0.47 [0.23, 0.99]
1 study · 75 participants
Low